Every 340B coordinator managing orphan drug exclusion cases eventually runs into the same wall: discounts that vanish the moment a drug carries an orphan designation. 340B Orphan Drug Solutions was built to close that gap, giving coordinators a practical way to pursue manufacturer discretionary pricing instead of writing off the savings entirely. Their team handles NDC identification and manufacturer outreach, so a 340B coordinator is not chasing agreements alone on top of daily compliance work. This matters most for critical access hospitals, rural referral centers, and sole community hospitals, where a small pharmacy team already wears too many hats. 

Coordinators who want a clearer process for orphan drug savings, rather than another manual tracking spreadsheet, can see how the program works at 340borphandrugsolutions.com.